VRTX
Vertex Pharmaceuticals Inc
Price:  
426.97 
USD
Volume:  
782,775.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Vertex Relative Valuation

2.6%
Upside

As of 2024-02-29, the Relative Valuation of Vertex Pharmaceuticals Inc (VRTX) is 438.22 USD. This relative valuation is based on P/E multiples. With the latest stock price at 426.97 USD, the upside of Vertex Pharmaceuticals Inc based on Relative Valuation is 2.6%.

The range of the Relative Valuation is 405.93 - 478.12 USD.

Range Selected
Trailing P/E multiples 31.2x - 34.0x 32.0x
Forward P/E multiples 26.6x - 29.6x 28.0x
Fair Price 405.93 - 478.12 438.22
Upside -4.9% - 12.0% 2.6%
426.97 USD
Stock Price
438.22 USD
Fair Price

Vertex Relative Valuation - Historical P/E Data

Date P/E
2024-02-28 30.40
2024-02-27 30.68
2024-02-26 30.86
2024-02-23 30.62
2024-02-22 30.38
2024-02-21 29.88
2024-02-20 29.95
2024-02-16 30.06
2024-02-15 30.35
2024-02-14 29.75
2024-02-13 29.62
2024-02-12 29.80
2024-02-09 30.11
2024-02-08 30.12
2024-02-07 29.84
2024-02-06 29.63
2024-02-05 30.54
2024-02-02 30.24
2024-02-01 30.89
2024-01-31 30.85
2024-01-30 31.76
2024-01-29 31.03
2024-01-26 30.63
2024-01-25 30.61
2024-01-24 30.44
2024-01-23 31.30
2024-01-22 31.33
2024-01-19 30.97
2024-01-18 30.83
2024-01-17 30.88
2024-01-16 31.15
2024-01-12 30.86
2024-01-11 30.62
2024-01-10 30.17
2024-01-09 29.97
2024-01-08 29.84
2024-01-05 29.65
2024-01-04 29.63
2024-01-03 29.24
2024-01-02 29.26
2023-12-29 28.97
2023-12-28 29.14
2023-12-27 29.05
2023-12-26 29.02
2023-12-22 28.85
2023-12-21 28.52
2023-12-20 28.50
2023-12-19 28.70
2023-12-18 28.81
2023-12-15 29.24